synovial fibroblast-derived exosomal microrna-106b suppresses chondrocyte proliferation and migration in rheumatoid arthritis via down-regulation of pdk4

Fibroblast-derived exosomes have been reported to transfer micrornas to recipient cells, where they regulate target gene expression, which is of interest for understanding the basic biology of inflammation, tissue homeostasis, and development of therapeutic approaches. initial microarray-based analysis carried out in this study identified the rheumatoid arthritis (ra)–related differentially expressed gene pyruvate dehydrogenase kinase 4 (pdk4). subsequently, the upstream regulatory microrna-106b (mir-106b) of pdk4 was predicted with bioinformatic analyses. a collagen-induced arthritis (cia)-induced mouse model was established, and exosomes were isolated from synovial fibroblasts (sfs) and transferred into chondrocytes to identify the role of exosomes in rheumatoid arthritis (ra). we found that pdk4 was poorly expressed in ra cartilage tissues and chondrocytes, while mir-106b was highly expressed in ra sfs and sf-derived exosomes. notably, pdk4 was confirmed as a target gene of mir-106b. over-expression of pdk4 promoted the proliferation and migration abilities of chondrocytes and inhibited their apoptosis as well as affected the receptor activator of nuclear factor kappa b ligand (rankl)/rank/osteoprotegerin (opg) system. meanwhile, mir-106b was delivered from sfs to chondrocytes through exosomes, which suppressed chondrocyte proliferation and migration and accelerated apoptosis as well as affected the rankl/rank/opg system via down-regulation of pdk4. furthermore, in vivo results validated that mir-106b inhibition could relieve cia-induced ra. taken together, sf-derived exosomal mir-106b stimulates ra initiation by targeting pdk4, indicating a physiologically validated potential approach for the prevention and treatment of ra.